Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 30,000 shares at $1.59 ($45K) on 2022-03-17, disclosed to the SEC on 2022-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.47 | 25,000 | $37K | 82.2% |
| 2 | $1.59 | 5,000 | $8K | 17.8% |
| Total | $1.49 avg | 30,000 | $45K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |